Close

Spark Therapeutics (ONCE) Updates on Voretigene Neparvovec Phase 3; Safety Profile Remained Consistent

Go back to Spark Therapeutics (ONCE) Updates on Voretigene Neparvovec Phase 3; Safety Profile Remained Consistent